PM360

SEPTEMBER 7, 2023

Therapeutic Talk: Doctors’ Reactions to Recent FDA Approvals in Respiratory, Gastro, Infectious Disease, and More The number of times HCPs mentioned new products approved by the FDA over the course of the month of May.

Healthcare 52

Healthcare Healthcare FDA Doctors 52

World of DTC Marketing

MARCH 10, 2022

market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money. Sales of Humira earned AbbVie $20.7 The executives at AbbVie make over $300 million.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Manufacturing 205

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. market (source: IQVIA MIDAS, May 2023). billion people in 2023). in the top five European Union markets and 7.1%

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

JUNE 30, 2023

Demand for process analytical technology ( PAT ) is being driven by the growing adoption of automation and digitalisation in sectors such as pharmaceutical industry, a report by Market.us With PAT being widely used in pharma, rising R&D expenses are anticipated to boost demand for these technologies.

Marketing 90

Marketing Manufacturing Pharmaceutical Pharmaceutical products 90

European Pharmaceutical Review

JULY 21, 2023

Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. What types of medicinal products are in short supply and why?

Pharmaceutical 93

Pharmaceutical Food and Drug Administration Transportation Manufacturing 93

Clarivate

MARCH 14, 2024

5] Regulatory developments and their impact In January of 2023, Denmark, Germany, the Netherlands, Sweden, and Norway proposed an EU-wide ban on a large cache of per- and polyfluoroalkyl substances (PFAS) under Registration, Evaluation, Authorization and Restriction of Chemicals (REACH).

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

Pharmaceutical Technology

MARCH 22, 2023

He adds that in the early 2000s there were no set standards for RFID in the pharma industry, so the compatibility between systems was not guaranteed. In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio.

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma FDA 105

PharmaKinnex

SEPTEMBER 2, 2022

Before you sit down for your Q4 planning session (we’ll cover that in our next blog), have you and your team stopped to consider what you could do to improve product life cycles in 2023? Keep reading to learn more about how PharmaKinnex can help your team extend product life cycles AND increase profitability by 10X!

Sales 52

Sales Marketing Pharmaceutical Pharmaceutical Sales 52

European Pharmaceutical Review

DECEMBER 27, 2023

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. Approved cellular and gene therapy products [Internet]. FDA; 2022 [cited 2023 Mar]. 6-8 Clinical recommendations also change. 2021;3(S1):6–10.

Manufacturing 82

Manufacturing Food and Drug Administration Patients Pharma 82

Pharmaceutical Technology

JANUARY 16, 2023

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. To some extent, the pharmaceutical sector is more resilient to these challenges than other industries.

Pharma 64

Pharma Manufacturing Pharmaceutical Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. To some extent, the pharmaceutical sector is more resilient to these challenges than other industries.

Pharma 52

Pharma Manufacturing Pharmaceutical Marketing 52

Pharmaceutical Technology

JUNE 8, 2023

Pfizer, in addition to promising carbon neutrality by the same date via a 46% reduction in direct emissions and 100% renewable electricity purchasing, says its North American operations will be entirely solar powered by the end of 2023. A similar theme is evident in company filings.

Pharmaceutical 52

Pharmaceutical Media Transportation Pharma 52